Developing the next generation of oncology therapies for patients.
Location: United States, California, San Diego
Employees: 1-10
Total raised: $150M
Investors 3
| Date | Name | Website |
| - | Foresite C... | foresiteca... |
| 30.08.2023 | OrbiMed | orbimed.co... |
| 06.06.2023 | SR One | srone.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.03.2024 | Series A | $150M | - |
Mentions in press and media 5
| Date | Title | Description |
| 14.05.2024 | Avenzo, BioAge-backer Sands Capital raises new $555M life sciences fund | Sands Capital has raised more than half a billion dollars for a new life science fund, readying a slew of new bets toward therapeutic, diagnostic and device companies. The Arlington, Virginia-based venture investor said Tuesday that the new... |
| 27.03.2024 | USA-based Avenzo Therapeutics raises USD 150 million in funding | California, USA-based clinical biotechnology company, Avenzo Therapeutics raises USD 150 Million in the funding. The company announced the fundraise on March 26, 2024. The total capital raised since the company’s inception in August 2022 is... |
| 27.03.2024 | Avenzo Therapeutics Raises $150M in Series A1- Financing | Avenzo Therapeutics, Inc., a San Diego, CA-based clinical-stage biotechnology company developing next generation oncology therapeutics, closed a $150m Series A-1 financing. The round, which brought total funding raised to date $347m, was le... |
| 26.03.2024 | Avenzo Therapeutics closes $150M Series A-1 round to advance their pipeline for oncology | - |
| - | Avenzo Therapeutics | “Developing the next generation of oncology therapies for patients.” |